Financhill
Sell
25

LPTX Quote, Financials, Valuation and Earnings

Last price:
$0.41
Seasonality move :
-6.71%
Day range:
$0.40 - $0.44
52-week range:
$0.22 - $4.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.13x
P/B ratio:
0.82x
Volume:
163K
Avg. volume:
324.5K
1-year change:
-81.37%
Market cap:
$17M
Revenue:
--
EPS (TTM):
-$1.70

Earnings Data

Next earnings date for LPTX
Aug 12
2025
Most recent earnings per share
-$0.37
Beat by $0.01
(May 13/2025)
Consensus Estimate
-$0.38
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LPTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/12/2025 Q2 -- -- -- -$0.29 --
05/13/2025 Q1 -- -- -$0.37 -$0.38 $0.01
03/26/2025 Q4 -- -- -$0.37 -$0.36 -$0.01
11/13/2024 Q3 -- -- -$0.44 -$0.47 $0.03
08/12/2024 Q2 -- -- -$0.52 -$0.41 -$0.12
05/13/2024 Q1 -- -- -$0.51 -$0.59 $0.08
03/18/2024 Q4 -- -- -$0.20 -$0.56 $0.36
11/13/2023 Q3 -- -- -$0.51 -$0.58 $0.07
06/30/2023 Q2 -- -- -$0.91 -$0.89 -$0.03
03/31/2023 Q1 -- -- -$3.24 -- --
12/31/2022 Q4 -- -- -$1.10 -- --
09/30/2022 Q3 -- -- -$1.33 -- --
06/30/2022 Q2 -- -- -$1.50 -- --
03/31/2022 Q1 -- -- -$0.90 -- --
12/31/2021 Q4 -- $375K -$1.00 -- --
09/30/2021 Q3 -- $375K -$1.40 -- --
06/30/2021 Q2 -- $375K -$1.20 -- --
03/31/2021 Q1 -- $375K -$1.20 -- --
12/31/2020 Q4 -- $375K -$0.90 -- --
09/30/2020 Q3 -- $375K -$0.90 -- --
06/30/2020 Q2 -- $375K -$1.20 -- --
03/31/2020 Q1 -- $375K -$5.50 -- --
12/31/2019 Q4 -- -- -$3.30 -- --
09/30/2019 Q3 -- -- -$3.30 -- --
06/30/2019 Q2 -- -- -$3.70 -- --
03/31/2019 Q1 -- -- -$4.70 -- --
12/31/2018 Q4 -- -- -$3.50 -- --
09/30/2018 Q3 -- -- -$5.50 -- --
06/30/2018 Q2 -- -- -$5.00 -- --
03/31/2018 Q1 -- -- -$8.50 -- --
12/31/2017 Q4 -- -- -$6.50 -- --
09/30/2017 Q3 -- -- -$7.30 -- --
06/30/2017 Q2 -- -- -$7.40 -- --
03/31/2017 Q1 -- -- -$13.90 -- --
12/31/2016 Q4 -- -- -$3.36 -- --
09/30/2016 Q3 -- -- -$4.26 -- --
06/30/2016 Q2 -- -- -$4.38 -- --
03/31/2016 Q1 -- -- -$3.01 -- --
12/31/2015 Q4 -- -- $4.31 -- --
09/30/2015 Q3 -- -- -$3.20 -- --
06/30/2015 Q2 -- -- -$3.60 -- --

Leap Therapeutics Earnings Questions

  • How Much did Leap Therapeutics Generate in Revenue Last Quarter?

    Leap Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Leap Therapeutics Beat Earnings Last Quarter?

    Leap Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$0.38 per share.

  • Is Leap Therapeutics Profitable?

    Leap Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Leap Therapeutics EPS Next Year?

    Leap Therapeutics's earnings are forecast to decrease from -$1.81 per share to -$1.82 per share next year representing a decrease of -38.67%.

  • When is Leap Therapeutics's Earnings Date?

    Leap Therapeutics's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock